Sernova Corp T.SVA

An excellent interview this morning

[steadfast]

Just finished watching Dr T present a very professional slide presentation.  Fortunately, to-date SVA
is keeping ahead of competition, we just have to ensure we continue to keep many steps ahead.
Product potential for diabetes $100,000 to $200,000 per patient.  Did not give time frame.
Great potential, just going to take time.  The immune protection will be The Holy Grail.

[Metalsguy1]

Really steadfast? You want to tempt fate with the Holy Grail analogy. It was never found. The knights were incompetent in their quest! Lol

[JonEcash]

For many of us here, no new information was provided. But it was still nice to see things put together in a formal presenation to hopefully bring in new investors. Lots in the pipeline and up to each to decide how patient they want to be. This can be traded for pennies until a license deal is announced. GLTA. J$ ps. part of the reason that liquidity is tight is there are a ton of legacy